Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival

L Martins, I Fonseca, M Almeida, AC Henriques… - Transplantation …, 2005 - Elsevier
We analyzed the impact of antithymocyte globulin (ATG) in renal transplantation. We
retrospectively studied 1217 recipients performed from July 83 to December 03. ATG-
Fresenius-S (ATG-F) was used for induction therapy in 492 patients (40.4%; group I) and
compared with group II, 725 patients (59.6%), without antilymphocyte induction. Groups
were comparable in terms of recipient gender and race distribution; time on dialysis; cause
of renal disease; number of human leukocyte antigen (HLA) mismatches; donor age …